v3.25.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2024
Dec. 31, 2023
Preferred shares, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 5,000,000 5,000,000
Preference shares, shares issued 0 0
Preferred stock, shares outstanding 0 0
Aspire Biopharma Inc [Member]    
Common shares, par value $ 0.00005 $ 0.00005
Common stock, shares authorized 750,000,000 750,000,000
Common stock, shares outstanding 440,000,000 440,000,000
Common Class A Subject to Redemption [Member]    
Temporary equity, par value $ 0.0001 $ 0.0001
Temporary equity, shares outstanding 577,644 1,803,729
Temporary equity, price per share $ 11.54 $ 11.03
Common Class A [Member]    
Common shares, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 7,187,500 7,187,500
Common stock, shares outstanding 7,187,500 7,187,500
Common Class B [Member]    
Common shares, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 50,000,000 50,000,000
Common stock, shares issued 0 0
Common stock, shares outstanding 0 0
Series A Preferred Stock [Member] | Aspire Biopharma Inc [Member]    
Preferred shares, par value $ 0.0001  
Preferred stock, shares authorized 25,000,000  
Preferred stock, shares outstanding 322,059 0